S Medicine Use Reviews NSAIDs NHS Specialist Pharmacy Services Medicines Use & Safety P S East & South East England Specialist Pharmacy Services East of.

Slides:



Advertisements
Similar presentations
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
Advertisements

INDIGESTION (DYSPEPSIA) AND HEARTBURN (ACID REFLUX)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 71 Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen.
Getting the most out of your Arthritis medicines & your Pharmacist Kathy Maxwell Community Pharmacist Hillpark Care Chemist, Manurewa.
Walsall Healthcare NHS Trust Medicines Management.
SUA
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
OPPORTUNITIES FOR RESEARCH IN PRIMARY CARE Jen Dumbleton Clinical Trial Manager University of Nottingham
Analgesics for Osteoarthritis — An Update Prepared for: Agency for Healthcare Research and Quality (AHRQ)
By Dan Alston.  Osteoarthritis “refers to a clinical syndrome of joint pain accompanied by varying degrees of functional limitation and reduced quality.
N ON - STEROIDAL ANTI - INFLAMMATORY DRUGS. OBJECTIVES At the end of the lecture the students should : Define NSAIDs Describe the classification of this.
NICE Decision Making Dr Katherine Payne North West Genetics Knowledge Park The University of Manchester
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast Research methods: answering questions.
IMPLEMENTING GUIDELINES AND REDUCING PATIENT RISK OF VENOUS THROMBOEMBOLISM IN A LARGE UK TEACHING HOSPITAL Sharron Millen, Head of Clinical Pharmacy and.
Power B, McQuoid P, Caldwell NA, Clareburt A. Pharmacy Department, Wirral Hospital NHS Trust, Wirral. Poster Layout & Design By Wirral Medical Illustration.
Primary Care Trigger Tool Manaia Health PHO Linda Holman Quality Leader.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
TORFAEN MEDICATION ADMINISTRATION SCHEME Val Bessell Wendy Tyler-Batt.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
Independent Prescriber- Sunnymeed Practice Community Pharmacist- Boots The Chemist Ltd Clinical Pharmacist for North West Surrey CCG.
Medicine used in the Treatment of Obesity
Medication Safety and admissions avoidance: A perspective Steve Williams Consultant Pharmacist in Medicine & Medication Safety Honorary Clinical Lecturer,
CRITICAL APPRAISAL OF ARTICLE ON HARM. Among patients with acute rheumatic fever, will administration of non steroidal anti- inflammatory drugs have adverse.
Cardiovascular Risk and NSAIDs Arthritis Advisory Committee Meeting November 29, 2006 Sharon Hertz, M.D. Deputy Director Division of Analgesia, Anesthesia,
NPS MEDICINEWISE Lynn Weekes Chief Executive.
Improving the effectiveness of integrated care teams Rob Darracott Pharmacy Voice.
NSAID Gastropathy Group B Lim, Imee – Lim, Mary. NSAIDS Weak organic acids that inhibit biosynthesis of prostaglandins Anti-inflammatory, analgesic, antipyretic,
Anticoagulants Reducing the risk Amanda Powell & Sue Wooller May 2014.
BHIVA PROMS / PREMS PROJECT A Community Consultation.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Community Pharmacy Cheshire & Wirral (CPCW) Helen Murphy Chief Executive Officer Community Pharmacy Cheshire and Wirral.
Summary Pattern of Specific COX II Inhibitors Use Physician prescribed appropriate COX II use in high risk was 40.08% and inappropriate COX II use in low.
CV Update – Guidelines & Debates Royal Pharmaceutical Society, Great Britain Barnet – 27/01/09 Dr Ameet Bakhai, FRCP – Cardiologist, Clinical Trials, Health.
Community Pharmacy Presentation for Hospital Pharmacists July 2015.
Central Norfolk Health & Social Care Central Norfolk Health and Social Care Better Care for Norfolk Key Partners: Norfolk & Norwich University Hospital.
NSAIDs.
South Central Respiratory Project MK Report 10 th October 2011 Nikki Hughes Community Pharmacy Lead NHS Milton keynes.
Medicines Optimisation Polypharmacy and Deprescribing
RA. F.A. is a 25-year-old woman with RA. On diagnosis 1 year ago, F.A. had an RF titer of 1:64, signs and symptoms of inflammation in the joints of both.
What about VIOXX?. Adenomatous Polyp Prevention on Vioxx (APPROVe) Vioxx (rofecoxib) versus Placebo Basic Clinical Trial Objective: Assess whether Vioxx.
Hot Topic Presentation Lars Halford, GP ST3 March 2010
An unpleasant sensory or emotional experience associated with actual or potential tissue damage The World Health Organization (WHO) has stated that pain.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast NSAIDS – Efficacy and Safety Expert speaker.
Educational solutions for the NHS pharmacy workforce Medicines Optimisation: Helping patients to make the most of medicines Sue Carter Regional Tutor
NHS Specialist Pharmacy Service Medicine Use Reviews NSAIDs NHS Specialist Pharmacy Service Medicines Use & Safety.
Polypharmacy Review T. Lewis GP. Six principles of medication review Patients should have a chance to raise questions and highlight problems about their.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast Medicine Use Reviews NSAIDs NHS Specialist.
Improving medicines adherence and reducing medicines waste: EAHSN/PrescQIPP- Strategy to develop joint working programme with the Pharmaceutical.
Pharmacy White Paper Building on Strengths Delivering the Future Overview.
NHS Specialist Pharmacy Service NSAIDS – efficacy and safety Expert speaker Slide set Key content from the NPC NSAIDS QIPP slides is gratefully acknowledged.
Clinical Knowledge Summaries CKS Analgesia – mild to moderate pain Prescribing analgesics for mild to moderate pain in adults and children. Educational.
PHARMACEUTICAL GUIDELINES: BASIC PRINCIPLES AND STATUTES.
PROTON PUMP INHIBITORS (PPI)
Graph to show the number of patients receiving management options
Liz Corteville, Medicines Optimisation
Chapter 71 Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen 1.
Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen 1.
Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
}   Recommended Acute Analgesia for Adult Patients
68.3 million errors (28% of total) cause moderate or serious harm
Can Proton Pump Inhibitor Deprescribing be Undertaken in a Scottish Community Pharmacy Setting? A Feasibility Study. Andrew Christopherson1,2, Alison H.
Medicines Safety Programme
Claire Vaughan- Head of Medicines Optimisation, Salford CCG
Patient Safety and Health Informatics
Non opioids pain management
Presentation transcript:

S Medicine Use Reviews NSAIDs NHS Specialist Pharmacy Services Medicines Use & Safety P S East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast Medicines Use and Safety ©East & South East England Specialist Pharmacy Services

S Introduction and welcome Housekeeping - Fire drills - Facilities - Refreshments P S Medicines Use and Safety

S Programme Objectives and warm up Expert presentation Activity one Activity two Presentation two NSAID MUR project presentation Activity three P S Medicines Use and Safety

S Objectives To revise and update your knowledge of NSAID efficacy and safety problems To develop communication and clinical skills to enhance the NSAID targeted MURs To understand how NSAID MURs have been used to improve NSAID safety To improve outcomes for patients taking NSAIDs To increase the number and efficacy of NSAID targeted MURs locally P S Medicines Use and Safety

S Warm-up Write down on a sticky note a number from 1-10 where 1 is not confident in doing MURs and 10 is very confident What is the biggest barrier for you doing MURs? P S Medicines Use and Safety

S Key facts quiz 10 questions seconds to discuss each answer in your groups P S Medicines Use and Safety

S Question 1 Are COX2 selective inhibitors more effective than traditional NSAIDs? P S Medicines Use and Safety

S Answer to question 1 Are COX2 selective inhibitors more effective than traditional NSAIDs? NO Similar efficacy to traditional NSAIDs such as diclofenac and naproxen P S Medicines Use and Safety

S Question 2 Does NICE guidance on osteoarthritis recommend use of topical NSAIDs? P S Medicines Use and Safety

S Answer to question 2 Does NICE guidance on osteoarthritis recommend use of topical NSAIDs? YES Like paracetamol, these should be considered before oral NSAIDs P S Medicines Use and Safety

S Question 3 Can ranitidine be used to prevent NSAID induced ulcers? P S Medicines Use and Safety

S Answer to question 3 Can ranitidine be used to prevent NSAID induced ulcers? YES But standard doses are not effective and PPIs are preferred P S Medicines Use and Safety

S Question 4 Can misoprostol be used to prevent NSAID induced ulcers? P S Medicines Use and Safety

S Answer to question 4 Can misoprostol be used to prevent NSAID induced ulcers? YES But misoprostol tends to be poorly tolerated P S Medicines Use and Safety

S Question 5 Should OTC ompeprazole be used to prevent NSAID induced ulcers? P S Medicines Use and Safety

S Answer to question 5 Should OTC omeprazole be used to prevent NSAID induced ulcers? NO OTC omeprazole is only licensed for heartburn and acid reflux P S Medicines Use and Safety

S Question 6 Should exercise be a core treatment for people with osteoarthritis, regardless of age and pain severity? P S Medicines Use and Safety

S Answer to question 6 Should exercise be a core treatment for people with osteoarthritis, regardless of age and pain severity? YES NICE advises exercise for all (irrespective of age, co morbidity, pain or disability) and weight loss if overweight or obese P S Medicines Use and Safety

S Question 7 Does NICE recommend using glucosamine in treatment of osteoarthritis? P S Medicines Use and Safety

S Answer to question 7 Does NICE recommend using glucosamine in treatment of osteoarthritis? NO The use of glucosamine or chondroitin products is not recommended for the treatment of osteoarthritis. Rubefacients are not recommended either. P S Medicines Use and Safety

S Question 8 Has use of naproxen increased because it has fewer GI adverse effects than other NSAIDs (eg diclofenac)? P S Medicines Use and Safety

S Answer to question 8 Has use of naproxen increased because it has fewer GI adverse effects than other NSAIDs (eg diclofenac)? NO Use has increased but this is because it appears to have lower cardiovascular risk than other NSAIDs, not lower GI risk. P S Medicines Use and Safety

S Question 9 Can NSAIDs be taken with methotrexate? P S Medicines Use and Safety

S Answer to question 9 Can NSAIDs be taken with methotrexate? Yes But NSAIDs reduce excretion of methotrexate so increase the toxicity. The dose of methotrexate needs to be carefully monitored and OTC NSAIDs avoided P S Medicines Use and Safety

S Question 10 Is OTC diclofenac 12.5mg a useful product? P S Medicines Use and Safety

S Answer to question 10 Is OTC diclofenac 12.5mg a useful product? ? This is a conundrum!! P S Medicines Use and Safety

S Expert presentation P S Medicines Use and Safety

S Activity One - Patients In your groups discuss the following: - What would make you feel more confident to do MURs? -What systems do you have in place to sign up people for MURs? -Share the ways you recruit reluctant patients (preworkshop activity) P S Medicines Use and Safety

S Activity Two - Prescribers In your groups, discuss whether or not you get feedback from GPs after doing MURs If not, think about how they might get this Share hints and tips about good ways of linking with GP surgeries P S Medicines Use and Safety

S Presentation NSAID MUR project P S Medicines Use and Safety

S Medicines related hospital admissions 6% of admissions due to problems with medicines Mostly preventable Most commonly NSAIDs, diuretics, anticoagulants and antiplatelets Howard et al Qual Saf Health Care 2003;12: P S Medicines Use and Safety

S Principles for MUR high risk drugs list Type of harm could be prevented by an MUR and the pharmacist will have the skills, knowledge and information to deliver it’ P S Medicines Use and Safety

S NSAIDs and preventable admissions LACK OF MONITORING Renal necrosis PRESCRIBING ISSUES GI bleed – 2+ risk factors no GI prophylaxis ADHERENCE ISSUES GI bleed - not taking GI prophylaxis GI bleed - self-medicating with OTC NSAIDs P S Medicines Use and Safety

S NSAIDs Widely used Effective anti-inflammatory and analgesic Adverse effects include - Renal - Cardiovascular - Gastro intestinal P S Medicines Use and Safety

S GI safety ‘Each year NSAIDs cause about 3,500 hospitalisations for, and 400 deaths from, ulcer bleeding in people aged 60 years or above.’ Drug & Therapeutics Bulletin Feb 2011 P S Medicines Use and Safety

S GI Safety PPI not prescribed - NICE guidance on OA, RA and people over 45 with chronic low back pain - GI prophylaxis with a PPI should be co-prescribed for all NSAID and COX2 patients PPI not taken Two NSAIDs taken concurrently - OTC as well as prescribed NSAID P S Medicines Use and Safety

S Isn’t NSAID safety fixed already? Survey of 100 MURs patients on NSAIDS 4 regular NSAID patients aged over 55 with no GI protection Local pharmacy snapshot December patients on regular NSAIDs 5 aged over 55 with no GI protection 4 not regularly collecting PPI OA patient survey % not offered GI prophylaxis P S Medicines Use and Safety

S Business case Put together in summer 2010 Support from CCG, PCT, LPC Information to all local GPs and CPs Educational grant from Pfizer P S Medicines Use and Safety

S The NSAID MUR Regular prescription for NSAID Focus GI safety PLUS preventing concomitant use of two NSAIDs from any outlet Two patient groups taking NSAIDs 1.Inadequate GI prophylaxis 2.Over 55s P S Medicines Use and Safety

S Data collection Smart-survey.co.uk or paper copy Show NSAID MURs being done Demonstrate value i.e. preventing adverse events and admissions P S Medicines Use and Safety

S Results 17 pharmacies involved (all types) 15 months (Jan 11 – Mar 12) 142 patients (Mean age 64) - 1% prescribed two NSAIDs - 8% patients taking OTC and prescribed NSAID - 3% patients taking other GI risk drugs P S Medicines Use and Safety

S Inadequate GI prophylaxis Four non-adherent to GI prophylaxis 82 no GI prophylaxis Collected follow up data on 48 patients - 23 (48%) GI prophylaxis started - 7 (15%) NSAID stopped - 4 (8%) reduced/less frequent NSAID dose - 8 (17%) prescriber/patient active decision not to change - 6 (12%) no change P S Medicines Use and Safety

S Examples 91 year old lady prescribed two NSAIDs, low dose aspirin but no PPI Patient stopped taking lansoprazole because of upset stomach, prescriber was unaware 85 year old lady on ibuprofen referred to GP re GI risk, prescribed omeprazole P S Medicines Use and Safety

S Overview of results NSAID MURS 63% had NSAID safety issue identified 7% improved safety during MUR (e.g. OTC NSAIDs identified or non-adherence to prophylaxis) Post MUR follow-up of GI safety 71% changed to improve safety P S Medicines Use and Safety

S 17 million NSAID Rx in England each year…. P S Medicines Use and Safety

S Activity Three – preworkshop task In your groups discuss your pre-workshop activity: Did you manage to find three patients with regular NSAIDs? Any of these over 75? Any of these with no gastro-protection? Have you done an MUR on any of these patients? P S Medicines Use and Safety

S Activity Four – Case Studies In your groups discuss the three vignettes You only have about 3-4 minutes for each one Feedback at the end P S Medicines Use and Safety

S Action plan Do you feel more confident? What are you going to do as a result of this learning? - Tomorrow or as soon as you return to work - Within a few weeks - Within a longer period (may involve further learning or accreditation) P S Medicines Use and Safety

S Reminder of Objectives To revise and update your knowledge of NSAID efficacy and safety problems To develop communication and clinical skills to enhance the NSAID targeted MURs To understand how NSAID MURs have been used to improve NSAID safety To improve outcomes for patients taking NSAIDs To increase the number and efficacy of NSAID targeted MURs locally P S Medicines Use and Safety